Nothing Special   »   [go: up one dir, main page]

AU2001234178A1 - Modified bdnf - Google Patents

Modified bdnf

Info

Publication number
AU2001234178A1
AU2001234178A1 AU2001234178A AU3417801A AU2001234178A1 AU 2001234178 A1 AU2001234178 A1 AU 2001234178A1 AU 2001234178 A AU2001234178 A AU 2001234178A AU 3417801 A AU3417801 A AU 3417801A AU 2001234178 A1 AU2001234178 A1 AU 2001234178A1
Authority
AU
Australia
Prior art keywords
modified bdnf
bdnf
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001234178A
Other languages
English (en)
Inventor
Rie Igarashi
Yutaka Mizushima
Chikao Nakayama
Hiroshi Noguchi
Mutsuo Taiji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharmaceuticals Co Ltd
LTT Institute Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
LTT Institute Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd, LTT Institute Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Publication of AU2001234178A1 publication Critical patent/AU2001234178A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001234178A 2000-02-29 2001-02-26 Modified bdnf Abandoned AU2001234178A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-53581 2000-02-29
JP2000053581 2000-02-29
PCT/JP2001/001422 WO2001064742A1 (fr) 2000-02-29 2001-02-26 Bdnf modifie

Publications (1)

Publication Number Publication Date
AU2001234178A1 true AU2001234178A1 (en) 2001-09-12

Family

ID=18574946

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001234178A Abandoned AU2001234178A1 (en) 2000-02-29 2001-02-26 Modified bdnf

Country Status (5)

Country Link
US (1) US6800607B2 (zh)
EP (1) EP1264844A4 (zh)
CN (1) CN1426422A (zh)
AU (1) AU2001234178A1 (zh)
WO (1) WO2001064742A1 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE025347T2 (en) 2003-03-19 2016-02-29 Biogen Ma Inc NOGO receptor binding protein
PT1776136E (pt) 2004-06-24 2012-12-05 Biogen Idec Inc Tratamento de estados que envolvem desmielinização
PA8678401A1 (es) 2005-06-06 2009-05-15 Wyeth Corp Anticuerpos monoclonales anti-trkb y sus usos
CA2614421A1 (en) 2005-07-08 2007-01-18 Biogen Idec Ma Inc. Sp35 antibodies and uses thereof
CA2997870A1 (en) 2008-07-09 2010-01-14 Biogen Ma Inc. Compositions comprising antibodies to lingo or fragments thereof
CN101412798B (zh) 2008-11-21 2011-08-10 优洁（亚洲）有限公司 软质聚氨酯低回弹泡沫及其制备方法
DK2396038T3 (en) * 2009-02-12 2016-02-01 Curna Inc TREATMENT OF BRAIN-DERIVATED NEUROTROPHIC FACTOR- (BDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENCE TRANSCRIPTION TO BDNF
JP2013530993A (ja) 2010-07-02 2013-08-01 アンジオケム インコーポレーテッド 治療用コンジュゲートのための短く且つｄ−アミノ酸を含有するポリペプチドおよびその使用
EA030716B1 (ru) 2012-05-14 2018-09-28 Байоджен Ма Инк. Антагонисты lingo-2 для лечения заболеваний, в которых участвуют двигательные нейроны
WO2016112270A1 (en) 2015-01-08 2016-07-14 Biogen Ma Inc. Lingo-1 antagonists and uses for treatment of demyelinating disorders
WO2017031392A1 (en) * 2015-08-20 2017-02-23 University Of Florida Research Foundation, Incorporated Lipid compounds for treatment of obesity, hypertension and metabolic syndrome

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109118A (en) * 1989-07-06 1992-04-28 Yutaka Mizushima Modified biologically active proteins
JP2679852B2 (ja) 1989-11-29 1997-11-19 株式会社サム研究所 経口及び局所投与用生物活性蛋白組成物
JP2718809B2 (ja) 1989-07-06 1998-02-25 株式会社サム研究所 修飾生物活性蛋白
US5770577A (en) * 1994-11-14 1998-06-23 Amgen Inc. BDNF and NT-3 polypeptides selectively linked to polyethylene glycol
JPH08208511A (ja) * 1995-01-31 1996-08-13 Samu Kenkyusho:Kk 抗運動ニューロン疾患剤
NZ336865A (en) 1997-01-23 2001-01-26 Sumitomo Pharma Use of a therapeutic agent containing a neurotrophic factor for treatment of diabetes and hyperlipemia

Also Published As

Publication number Publication date
US6800607B2 (en) 2004-10-05
CN1426422A (zh) 2003-06-25
US20030073631A1 (en) 2003-04-17
WO2001064742A1 (fr) 2001-09-07
EP1264844A1 (en) 2002-12-11
EP1264844A4 (en) 2004-08-18

Similar Documents

Publication Publication Date Title
AU6419701A (en) Electropancreatography
AU2001262847A1 (en) Language-understanding
AU2001292739A1 (en) 1-oxorapamycins
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2002211620A1 (en) Autoanastomosis
AU2001258349A1 (en) Bisacylguanidine
AU2001296577A1 (en) Chlorophyllases
AU2001279754A1 (en) Indoloquinazolinones
AU2002211128A1 (en) Step-bike
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU2001290931A1 (en) Ski-snowboard
AU2001258924A1 (en) Microsatellite-aflp
AU2001293852A1 (en) Sulfonylguanidine
AU2001234178A1 (en) Modified bdnf
AU2002226346A1 (en) 2-aryl-5-trifluoromethylpyridines
AU2001281921A1 (en) Bdellosomes
AU2001291876A1 (en) Triazolo-epothilones
AU2001246864A1 (en) Hypotensors
AU2002214354A1 (en) Neck-phone
AU2001295713A1 (en) Blast-processing
AU2001284173A1 (en) Calycins
AU2001262711A1 (en) Cytoprotectors